Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: A preliminary study
2011

Bimatoprost for Angle-Closure Glaucoma

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Vyas Prateep, Naik Uday, Gangaiah Jayasheel

Primary Institution: Choithram Netralaya, Indore, India

Hypothesis

Does bimatoprost 0.03% effectively lower intraocular pressure in patients with 360° synechial angle-closure glaucoma?

Conclusion

Bimatoprost 0.03% significantly reduces intraocular pressure in patients with 360° synechial angle-closure glaucoma.

Supporting Evidence

  • The mean reduction in intraocular pressure was 15.3 ± 9.5 mmHg after 8 weeks of treatment.
  • Conjunctival hyperemia was the most common side effect, occurring in 35% of patients.
  • 85% of patients had unilateral angle-closure glaucoma.

Takeaway

This study found that a medicine called bimatoprost can help lower eye pressure in people with a specific type of glaucoma.

Methodology

This was a prospective, non-randomized, single-center pilot study involving 20 patients treated with bimatoprost for 8 weeks.

Limitations

The study had a small sample size and a short duration.

Participant Demographics

Participants were Indian patients aged 40 to 70 years, with a majority being female (65%).

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.4103/0301-4738.73708

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication